Ole Torffvit

3.1k total citations
96 papers, 2.1k citations indexed

About

Ole Torffvit is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ole Torffvit has authored 96 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Nephrology, 24 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ole Torffvit's work include Chronic Kidney Disease and Diabetes (39 papers), Renal Diseases and Glomerulopathies (18 papers) and Diabetes Treatment and Management (12 papers). Ole Torffvit is often cited by papers focused on Chronic Kidney Disease and Diabetes (39 papers), Renal Diseases and Glomerulopathies (18 papers) and Diabetes Treatment and Management (12 papers). Ole Torffvit collaborates with scholars based in Sweden, Denmark and United States. Ole Torffvit's co-authors include Bengt Rippe, Elisabet Agardh, Jan Tencer, C.‐D. AGARDH, Omran Bakoush, Carl‐David Agardh, Anders Grubb, Monica Lövestam‐Adrian, Johan Jendle and E. Agardh and has published in prestigious journals such as Diabetes Care, Diabetes and Kidney International.

In The Last Decade

Ole Torffvit

95 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Torffvit Sweden 30 710 584 332 318 278 96 2.1k
Radovan Hojs Slovenia 24 1.1k 1.6× 429 0.7× 546 1.6× 294 0.9× 374 1.3× 136 2.6k
Allan Kofoed‐Enevoldsen Denmark 20 1.0k 1.4× 962 1.6× 914 2.8× 280 0.9× 243 0.9× 49 2.6k
H.-H. Parving Denmark 18 735 1.0× 989 1.7× 769 2.3× 231 0.7× 241 0.9× 30 2.1k
G C Viberti United Kingdom 13 1.3k 1.8× 989 1.7× 701 2.1× 176 0.6× 235 0.8× 21 2.4k
Daniel Gordin Finland 31 473 0.7× 1.0k 1.7× 849 2.6× 304 1.0× 229 0.8× 93 2.7k
Mari-Anne Gall Denmark 17 667 0.9× 797 1.4× 725 2.2× 253 0.8× 169 0.6× 26 2.1k
Maria Luiza Caramori United States 16 1.3k 1.8× 852 1.5× 395 1.2× 555 1.7× 165 0.6× 32 2.7k
E. R. Mathiesen Denmark 15 1.1k 1.5× 1.3k 2.2× 730 2.2× 141 0.4× 159 0.6× 30 2.3k
Richard E. Gilbert Australia 24 758 1.1× 839 1.4× 681 2.1× 579 1.8× 230 0.8× 44 2.2k
Tetsuya Babazono Japan 33 1.2k 1.7× 1.2k 2.0× 649 2.0× 632 2.0× 212 0.8× 143 3.3k

Countries citing papers authored by Ole Torffvit

Since Specialization
Citations

This map shows the geographic impact of Ole Torffvit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Torffvit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Torffvit more than expected).

Fields of papers citing papers by Ole Torffvit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Torffvit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Torffvit. The network helps show where Ole Torffvit may publish in the future.

Co-authorship network of co-authors of Ole Torffvit

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Torffvit. A scholar is included among the top collaborators of Ole Torffvit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Torffvit. Ole Torffvit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swärd, Per, et al.. (2020). Patterns of urinary albumin and IgM associate with markers of vascular ageing in young to middle-aged individuals in the Malmö offspring study. BMC Cardiovascular Disorders. 20(1). 358–358. 4 indexed citations
2.
Jendle, Johan, et al.. (2012). Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results. Journal of Medical Economics. 15(sup2). 1–5. 20 indexed citations
3.
Torffvit, Ole, et al.. (2011). Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy. Diabetes Research and Clinical Practice. 95(1). 139–144. 17 indexed citations
4.
Torffvit, Ole, et al.. (2008). Tubular function in diabetic children assessed by Tamm-Horsfall protein and glutathione S-transferase. Pediatric Nephrology. 23(7). 1079–1083. 16 indexed citations
5.
Kalani, Majid, Angela Silveira, Margareta Blombäck, et al.. (2007). Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thrombosis Research. 120(5). 653–661. 31 indexed citations
6.
Torffvit, Ole, et al.. (2004). Urinary Excretion Rate of Tamm-Horsfall Protein Is Related to Salt Intake in Humans. Nephron Physiology. 97(1). p31–p36. 35 indexed citations
7.
Torffvit, Ole, et al.. (2003). Metabolic status in diabetes mellitus affects markers for glomerular filtration rate. Pediatric Nephrology. 18(6). 536–540. 19 indexed citations
8.
Strevens, Helena, Dag Wide‐Swensson, Ole Torffvit, & Anders Grubb. (2002). Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scandinavian Journal of Clinical and Laboratory Investigation. 62(2). 141–147. 76 indexed citations
9.
Torffvit, Ole, Anne‐Lise Kamper, Niels‐Henrik Holstein‐Rathlou, et al.. (1998). Urinary Excretion of Tamm-Horsfall Protein and Epidermal Growth Factor in Chronic Nephropathy. ˜The œNephron journals/Nephron journals. 79(2). 167–172. 37 indexed citations
10.
Tencer, Jan, Ole Torffvit, Hans Thysell, Bengt Rippe, & Anders Grubb. (1998). Proteinuria selectivity index based upon α2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Kidney International. 54(6). 2098–2105. 38 indexed citations
11.
Thulesen, Jesper, Per E. Jørgensen, Ole Torffvit, Ebba Nexø, & Steen Seier Poulsen. (1997). Urinary excretion of epidermal growth factor and Tamm–Horsfall protein in three rat models with increased renal excretion of urine. Regulatory Peptides. 72(2-3). 179–186. 25 indexed citations
12.
AGARDH, C.‐D., Elisabet Agardh, & Ole Torffvit. (1997). The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Research and Clinical Practice. 35(2-3). 113–121. 39 indexed citations
13.
Catalano, Carlo & Ole Torffvit. (1996). Urinary Excretion of Tamm-Horsfall Protein in Normotensive, Normo-Albuminuric Type 1 Diabetic Patients. ˜The œNephron journals/Nephron journals. 72(3). 436–441. 12 indexed citations
14.
Rasch, Ruth, Ole Torffvit, Silke Bachmann, Peter Koch Jensen, & N Jacobsen. (1995). Tamm?Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabetologia. 38(5). 525–535. 1 indexed citations
15.
Agardh, E., C.–D. Agardh, & Ole Torffvit. (1994). A 5‐year follow‐up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk indicators. Journal of Internal Medicine. 235(4). 353–358. 9 indexed citations
16.
Agardh, E., C.‐D. AGARDH, Sasha Koul, & Ole Torffvit. (1994). A Four‐year Follow‐up Study on the Incidence of Diabetic Retinopathy in Older Onset Diabetes Mellitus. Diabetic Medicine. 11(3). 273–278. 32 indexed citations
17.
Torffvit, Ole & C.‐D. AGARDH. (1993). Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy. Journal of Internal Medicine. 233(2). 131–137. 27 indexed citations
18.
Torffvit, Ole, Jörgen Wieslander, L. Forsberg, E. Hederström, & Carl‐David Agardh. (1990). Urinary excretion of the carboxy terminal domain of type IV collagen is associated with kidney size and function in IDDM. Journal of Diabetic Complications. 4(4). 166–169. 4 indexed citations
19.
Agardh, E., Ole Torffvit, & C.‐D. AGARDH. (1989). The prevalence of retinopathy and associated medical risk factors in type I (insulin‐dependent) diabetes mellitus. Journal of Internal Medicine. 226(1). 47–52. 32 indexed citations
20.
Agardh, E., Ole Torffvit, & C.‐D. AGARDH. (1989). Putative Risk Factors Associated with Retinopathy in Patients with Diabetes Diagnosed at or after 30 Years of Age. Diabetic Medicine. 6(8). 724–727. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radovan Hojs Breakdown of academic impact, for papers by Allan Kofoed‐Enevoldsen Breakdown of academic impact, for papers by H.-H. Parving Breakdown of academic impact, for papers by G C Viberti Breakdown of academic impact, for papers by Daniel Gordin Breakdown of academic impact, for papers by Mari-Anne Gall Breakdown of academic impact, for papers by Maria Luiza Caramori Breakdown of academic impact, for papers by E. R. Mathiesen Breakdown of academic impact, for papers by Richard E. Gilbert Breakdown of academic impact, for papers by Tetsuya Babazono
Rankless by CCL
2026